Israel Englander’s IO Biotech IOBT Stock Holding History

Israel Englander’s Portfolio IOBT Stock Details IOBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-194,158	Closed	-$11.4K	–	6112
2026 Q1	$11.4K	Buy	194,158 +55,442	+40%	+$18.9K	﹤0.01%	5531
2025 Q4	$84.5K	Sell	138,716 -1,253,680	-90%	-$932K	﹤0.01%	5658
2025 Q3	$506K	Buy	+1,392,396	New	+$2.4M	﹤0.01%	5066
2023 Q2	–	Sell	-19,917	Closed	-$37K	–	6383
2023 Q1	$37K	Sell	19,917 -637	-3%	-$1.59K	﹤0.01%	5717
2022 Q4	$47K	Sell	20,554 -17,768	-46%	-$47K	﹤0.01%	5793
2022 Q3	$104K	Sell	38,322 -7,909	-17%	-$29.3K	﹤0.01%	5947
2022 Q2	$216K	Sell	46,231 -26,497	-36%	-$162K	﹤0.01%	5593
2022 Q1	$385K	Sell	72,728 -5,235	-7%	-$34.6K	﹤0.01%	5327
2021 Q4	$512K	Buy	+77,963	New	+$753K	﹤0.01%	5021

Israel Englander's IOBT Position: Q2 2026 in Review

Israel Englander sold out of IO Biotech (IOBT) in Q2 2026, closing a stake of 194,158 shares — an estimated $11.4K sold.

Israel Englander first reported a position in IOBT in Q4 2021 and held it in 9 quarters. The position peaked at $512K in Q4 2021. 0 funds tracked by Wall St. Rank hold IOBT as of Q2 2026.

Israel Englander reported no remaining IO Biotech position as of Q2 2026 after selling out during the quarter.
Israel Englander sold 194,158 IO Biotech shares in Q2 2026, an estimated $11.4K.
Israel Englander first reported a position in IO Biotech in Q4 2021 and held it in 9 quarters.
Israel Englander's IO Biotech position peaked at $512K in Q4 2021.
0 funds tracked by Wall St. Rank held IO Biotech as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.